661 related articles for article (PubMed ID: 30831392)
21. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
[TBL] [Abstract][Full Text] [Related]
22. Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.
Brissos RF; Clavero P; Gallen A; Grabulosa A; Barrios LA; Caballero AB; Korrodi-Gregório L; Pérez-Tomás R; Muller G; Soto-Cerrato V; Gamez P
Inorg Chem; 2018 Dec; 57(23):14786-14797. PubMed ID: 30444630
[TBL] [Abstract][Full Text] [Related]
23. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
[TBL] [Abstract][Full Text] [Related]
24. Anticancer Activity of Iridium(III) Complexes Based on a Pyrazole-Appended Quinoline-Based BODIPY.
Paitandi RP; Mukhopadhyay S; Singh RS; Sharma V; Mobin SM; Pandey DS
Inorg Chem; 2017 Oct; 56(20):12232-12247. PubMed ID: 28956596
[TBL] [Abstract][Full Text] [Related]
25. Palladium(II) complexes of tridentate bis(benzazole) ligands: Structural, substitution kinetics, DNA interactions and cytotoxicity studies.
Omondi RO; Bellam R; Ojwach SO; Jaganyi D; Fatokun AA
J Inorg Biochem; 2020 Sep; 210():111156. PubMed ID: 32645652
[TBL] [Abstract][Full Text] [Related]
26. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
[TBL] [Abstract][Full Text] [Related]
27. Anticancer and antibacterial potential of robust Ruthenium(II) arene complexes regulated by choice of α-diimine and halide ligands.
Zanda E; Busto N; Biancalana L; Zacchini S; Biver T; Garcia B; Marchetti F
Chem Biol Interact; 2021 Aug; 344():109522. PubMed ID: 34029541
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and preliminary biological evaluation for the anticancer activity of organochalcogen (S/se) tethered chrysin-based organometallic Ru
Yadav S; Singh JD
J Biomol Struct Dyn; 2019 Aug; 37(13):3337-3353. PubMed ID: 30124119
[TBL] [Abstract][Full Text] [Related]
29. Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.
Filak LK; Mühlgassner G; Jakupec MA; Heffeter P; Berger W; Arion VB; Keppler BK
J Biol Inorg Chem; 2010 Aug; 15(6):903-18. PubMed ID: 20369265
[TBL] [Abstract][Full Text] [Related]
30. Similarities and differences in d
Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
[TBL] [Abstract][Full Text] [Related]
31. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
[TBL] [Abstract][Full Text] [Related]
32. Ligand Design for N, O- or N, N-Pyrazolone-Based Hydrazones Ruthenium(II)-Arene Complexes and Investigation of Their Anticancer Activity.
Pettinari R; Marchetti F; Di Nicola C; Pettinari C; Galindo A; Petrelli R; Cappellacci L; Cuccioloni M; Bonfili L; Eleuteri AM; Guedes da Silva MFC; Pombeiro AJL
Inorg Chem; 2018 Nov; 57(22):14123-14133. PubMed ID: 30362721
[TBL] [Abstract][Full Text] [Related]
33. DNA Binding Behavior, Sensor Studies, Antimicrobial, Photocleavage and In vitro Cytotoxicity of Synthesized Ru(II) Complexes with Assorted Intercalating Polypyridyl Ligands.
Mallepally RR; Putta VR; Chintakuntla N; Vuradi RK; Kotha LR; Sirasani S
J Fluoresc; 2016 May; 26(3):1101-13. PubMed ID: 27067208
[TBL] [Abstract][Full Text] [Related]
34. Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.
Bhattacharyya S; Purkait K; Mukherjee A
Dalton Trans; 2017 Jul; 46(26):8539-8554. PubMed ID: 28638907
[TBL] [Abstract][Full Text] [Related]
35. Development of novel ruthenium(II)-arene complexes displaying potent anticancer effects in glioblastoma cells.
Kumar P; Mondal I; Kulshreshtha R; Patra AK
Dalton Trans; 2020 Oct; 49(38):13294-13310. PubMed ID: 32936191
[TBL] [Abstract][Full Text] [Related]
36. Ru(II)-
Dorairaj DP; Haribabu J; Dharmasivam M; Malekshah RE; Mohamed Subarkhan MK; Echeverria C; Karvembu R
Inorg Chem; 2023 Jul; 62(30):11761-11774. PubMed ID: 37459067
[TBL] [Abstract][Full Text] [Related]
37. Ruthenium(II) piano stool coordination compounds with aminomethylphosphanes: Synthesis, characterisation and preliminary biological study in vitro.
Płotek M; Starosta R; Komarnicka UK; Skórska-Stania A; Kołoczek P; Kyzioł A
J Inorg Biochem; 2017 May; 170():178-187. PubMed ID: 28259056
[TBL] [Abstract][Full Text] [Related]
38. Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.
Beckford F; Dourth D; Shaloski M; Didion J; Thessing J; Woods J; Crowell V; Gerasimchuk N; Gonzalez-Sarrías A; Seeram NP
J Inorg Biochem; 2011 Aug; 105(8):1019-29. PubMed ID: 21666776
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells.
Pavlović M; Tadić A; Gligorijević N; Poljarević J; Petrović T; Dojčinović B; Savić A; Radulović S; Grgurić-Šipka S; Aranđelović S
J Inorg Biochem; 2020 Sep; 210():111155. PubMed ID: 32768729
[TBL] [Abstract][Full Text] [Related]
40. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
